Xml Financial, LLC Novartis Ag Transaction History

Xml Financial, LLC

$1.07 Billion
Q3 2024

A detailed history of Xml Financial, LLC transactions in Novartis Ag stock. As of the latest transaction made, Xml Financial, LLC holds 9,799 shares of NVS stock, worth $1.02 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

9,799

Previous 9,248 5.96%

Holding current value

$1.02 Million

Previous $984,000 14.53%

% of portfolio

0.11%

Previous 0.1%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$106.13 - $120.89 $58,477 - $66,610	551 Added 5.96%	9,799 $1.13 Million
Q2 2024 Jul 22, 2024	SELL	$92.57 - $107.37 $39,527 - $45,846	-427 Reduced 4.41%	9,248 $984,000
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $230,077 - $261,955	-2,415 Reduced 19.98%	9,675 $935,000
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $3,783 - $4,163	-41 Reduced 0.34%	12,090 $1.22 Million
Q3 2023 Nov 06, 2023	BUY	$94.73 - $105.13 $12,978 - $14,402	137 Added 1.14%	12,131 $1.24 Million
Q2 2023 Aug 07, 2023	SELL	$92.52 - $104.91 $53,199 - $60,323	-575 Reduced 4.57%	11,994 $1.21 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $33,612 - $38,980	-420 Reduced 3.23%	12,569 $1.16 Million
Q4 2022 Feb 09, 2023	BUY	$75.55 - $92.52 $15,110 - $18,504	200 Added 1.56%	12,989 $1.18 Million
Q3 2022 Nov 04, 2022	BUY	$74.61 - $87.26 $954,187 - $1.12 Million	12,789 New	12,789 $972,000
Q2 2022 Aug 01, 2022	SELL	$80.52 - $93.75 $1.03 Million - $1.2 Million	-12,749 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$80.11 - $90.62 $240 - $271	3 Added 0.02%	12,749 $1.12 Million
Q3 2021 Nov 01, 2021	BUY	$81.78 - $95.14 $1.04 Million - $1.21 Million	12,746 New	12,746 $1.04 Million

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xml Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xml Financial, LLC with notifications on news.

Account

Xml Financial, LLC Novartis Ag Transaction History